CoChat

Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor γ2 F77I point mutation

Open access
Cope, D. W., Halbsguth, C., Karayannis, T., Wulff, P., Ferraguti, F., Hoeger, H., Leppä, E., Linden, A.‐M., Oberto, A., Ogris, W., Korpi, E. R., Sieghart, W., Somogyi, P., Wisden, W., Capogna, M. · 2005 · European Journal of Neuroscience
Cited by 39

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Zolpidem is a hypnotic benzodiazepine site agonist with some γ‐aminobutyric acid (GABA)A receptor subtype selectivity. Here, we have tested the effects of zolpidem on the hippocampus of γ2 subunit (γ2F77I) point mutant mice. Analysis of forebrain GABA A receptor expression with immunocytochemistry, quantitative [3 H]muscimol and [35 S] t‐butylbicyclophosphorothionate (TBPS) autoradiography, membrane binding with [3 H]flunitrazepam and [3 H]muscimol, and comparison of miniature inhibitory postsynaptic current (mIPSC) parameters did not reveal any differences between homozygous γ2I77/I77 and γ2F77/F77 mice. However, quantitative immunoblot analysis of γ2I77/I77 hippocampi showed some increased levels of γ2, α1, α4 and δ subunits, suggesting that differences between strains may exist in unassembled subunit levels, but not in assembled receptors. Zolpidem (1 µ m) enhanced the decay of mIPSCs in CA1 pyramidal cells of control (C57BL/6J, γ2F77/F77) mice by ∼ 60%, and peak amplitude by ∼ 20% at 33–34 °C in vitro. The actions of zolpidem (100 n m or 1 µ m) were substantially reduced in γ2I77/I77 mice, although residual effects included a 9% increase in decay and 5% decrease in peak amplitude. Similar results were observed in CA1 stratum oriens/alveus interneurons. At network level, the effect of zolpidem (10 µ m) on carbachol‐induced oscillations in the CA3 area of γ2I77/I77 mice was significantly different compared with controls. Thus, the γ2F77I point mutation virtually abolished the actions of zolpidem on GABA A receptors in the hippocampus. However, some residual effects of zolpidem may involve receptors that do not contain the γ2 subunit.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1460-9568.2005.04127.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 39

Metadata

Authors
Cope, D. W., Halbsguth, C., Karayannis, T., Wulff, P., Ferraguti, F., Hoeger, H., Leppä, E., Linden, A. ‐., Oberto, A., Ogris, W., Korpi, E. R., Sieghart, W., Somogyi, P., Wisden, W., & Capogna, M.
Venue
European Journal of Neuroscience
Publisher
Wiley
Published
2005-06
Volume
21
Issue
11
Pages
3002-3016
ISSN
  • 0953-816X (ISSN-L)
  • 1460-9568
OpenAlex
W2103894607
Cited by
39
References
10
FWCI
0.91
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor γ2 F77I point mutation. https://app.cochat.ai/papers/10.1111/j.1460-9568.2005.04127.x
The paper
Cope, D. W., Halbsguth, C., Karayannis, T., Wulff, P., Ferraguti, F., Hoeger, H., Leppä, E., Linden, A. ‐., Oberto, A., Ogris, W., Korpi, E. R., Sieghart, W., Somogyi, P., Wisden, W., & Capogna, M. (2005). Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor γ2 F77I point mutation. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2005.04127.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.